Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral Agents
Petter I. Andersen, Aleksandr Ianevski, Hilde Lysvand, et al.
(2019)
Open Access | Times Cited: 20

Showing 20 citing articles:

Molecular Docking of Natural Compounds from Tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 Protein Targets
Arun Kumar
Biology Engineering Medicine and Science Reports (2020) Vol. 6, Iss. 1, pp. 11-13
Open Access | Times Cited: 36
Phytotherapeutic Evidence Against Coronaviruses and Prospects for COVID-19
Abdullahi Temitope Jamiu, Christiana Eleojo Aruwa, Ismail Abiodun Abdulakeem, et al.
Pharmacognosy Journal (2020) Vol. 12, Iss. 6, pp. 1252-1267
Open Access | Times Cited: 20
Interim Management of COVID-19 by Repurposed Homeopathic Medicines
N Basu, Bhudev C. Das, Simran Tandon
Homeopathy (2020) Vol. 109, Iss. 03, pp. 182-183
Open Access | Times Cited: 12
Molecular docking of natural compounds from tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 protein targets
Arun Kumar
Research Square (Research Square) (2020)
Open Access | Times Cited: 11
Acetamido-propanoic Acid Derived Compounds as Protease Inhibitors to Target Coronaviruses
Arun Kumar, Vikram Sharma
Biology Engineering Medicine and Science Reports (2020) Vol. 5, Iss. 2, pp. 20-22
Open Access | Times Cited: 9
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
Bruno O. Villoutreix, Rajagopal Krishnamoorthy, Ryad Tamouza, et al.
(2021)
Open Access | Times Cited: 7
Data-Driven Drug Repurposing for COVID-19
Raghvendra Mall, Abdurrahman Elbasir, Hossam Al Meer, et al.
(2020)
Open Access | Times Cited: 6
Predicting Drugs for COVID-19/SARS-CoV-2 via Heterogeneous Graph Attention Networks
Yahui Long, Yu Zhang, Min Wu, et al.
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (2020), pp. 455-459
Closed Access | Times Cited: 4
Data-Driven Drug Repurposing for COVID-19
Raghvendra Mall, Abdurrahman Elbasir, Hossam Al Meer, et al.
(2020)
Closed Access | Times Cited: 3
<strong></strong>Evaluation of Complex Carbohydrates Showing Broad-Spectrum Antiviral Activity against SARS-CoV-2, Influenza-a (H1N1) and Human Respiratory Syncytial Virus (hRSV) Strain A2 in ‘In Vitro’ Setting
David Platt, Alben Sigamani, Nehal Shah
(2023)
Open Access | Times Cited: 1
Neighborhood-based Inference and Restricted Boltzmann Machine for microbe and drug associations prediction
Xiaolong Cheng, Jia Qu, Tongguang Ni, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Covid-19 and Heart Diseases: A Scientometric Assessment of Global Publications during 2020-21
Gupta BM Gupta, Surulinathi M Surulinathi, Jivesh Bansal, et al.
Journal of Young Pharmacists (2021) Vol. 13, Iss. 3s, pp. s78-s83
Open Access | Times Cited: 1
Potential SARS-CoV-2 Nonstructural Protein 15 (NSP15) Inhibitors: Repurposing FDA-Approved Drugs
Jason Y Tang, Igor F. Tsigelny, Jerry P. Greenberg, et al.
(2021)
Open Access | Times Cited: 1
COVID 19: A Strange Worldwide Pandemic
Sneha Lodhi
Psychology and Education Journal (2021) Vol. 58, Iss. 2, pp. 719-729
Open Access
Pharmacophore Investigations of Potential COVID-19 RNA Polymerase (Rdrp) Inhibitors: Repurposing FDA-Approved Drugs
Valentina L. Kouznetsova, Caroline Kellogg, Aidan Zhang, et al.
Microbiology & Infectious Diseases (2021) Vol. 5, Iss. 1
Open Access
Potential SARS-CoV-2 Nonstructural Protein 15 (NSP15) Inhibitors: Repurposing FDA-Approved Drugs
Jason Y Tang, Igor F. Tsigelny, Jerry P. Greenberg, et al.
(2021)
Open Access
Identification and Semisynthesis of (–)-Anisomelic Acid as an Oral Antiviral Agent against SARS-CoV-2 in Mice
Hai‐Xin Yu, Nan Zheng, Chi‐Tai Yeh, et al.
(2021)
Open Access
Identification and Semisynthesis of (–)-Anisomelic Acid as an Oral Antiviral Agent against SARS-CoV-2 in Mice
Hai‐Xin Yu, Nan Zheng, Chi‐Tai Yeh, et al.
(2021)
Open Access
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
Bruno O. Villoutreix, Rajagopal Krishnamoorthy, Ryad Tamouza, et al.
(2021)
Open Access
Page 1

Scroll to top